Should Investors Like Bristol-Myers' Buyout of Celgene?
The pharmaceutical giant’s $74 billion bid for the biotechnology player sent the acquirer’s shares significantly lower, but that’s hardly unusual.
via FOX BUSINESS NEWS https://fxn.ws/2Ty5ty5
Monday, January 7, 2019
FOX BIZ NEWS: Should Investors Like Bristol-Myers' Buyout of Celgene?
Should Investors Like Bristol-Myers' Buyout of Celgene?
The pharmaceutical giant’s $74 billion bid for the biotechnology player sent the acquirer’s shares significantly lower, but that’s hardly unusual.
via FOX BUSINESS NEWS https://fxn.ws/2Ty5ty5
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment